Results 41 to 50 of about 117,235 (282)

Heart failure with preserved ejection fraction and diabetes mellitus [PDF]

, 2012
Heart failure with preserved ejection fraction (HFpEF) constitutes approximately 50% of heart failure patients. The prevalence of diabetes mellitus in HFpEF is high at 30-40%.
Cassar, Andrew, Fava, Stephen, Felice, Herbert, Magri, Caroline Jane   +3 more
core   +1 more source

The Prognostic Role of the Left Atrium in Hypertensive Patients with HFpEF: Does Function Matter More than Structure?

Life
Background: In arterial hypertension (AH), adverse hemodynamic consequences in the left atrium (LA) are often observed. The prognostic significance of functional vs.
Artem Ovchinnikov, Alexandra Potekhina, Anastasiia Filatova, Olga Svirida, Maria Sobolevskaya, Alfiya Safiullina, Fail Ageev   +6 more
doaj   +1 more source

The relationship between left ventricular wall thickness, myocardial shortening and ejection fraction in hypertensive heart disease:insights from cardiac magnetic resonance: LVH independently augments EF in hypertension [PDF]

, 2016
Hypertensive heart disease is often associated with a preserved left ventricular ejection fraction despite impaired myocardial shortening. The authors investigated this paradox in 55 hypertensive patients (52±13 years, 58% male) and 32 age‐ and sex ...
Bucciarelli-Ducci, Chiara, Burchell, Amy E, Dastidar, Amardeep Ghosh, Hamilton, Mark C K, Hart, Emma C, MacIver, David H, Manghat, Nathan E, Nightingale, Angus K, Paton, Julian F R, Ratcliffe, Laura E K, Rodrigues, Jonathan C L, Rohan, Stephen, Szantho, Gergely, Trickey, Adam   +13 more
core   +2 more sources

Current Treatment of Heart Failure with Preserved Ejection Fraction: Should We Add Life to the Remaining Years or Add Years to the Remaining Life?

Cardiology Research and Practice, 2013
According to the ejection fraction, patients with heart failure may be divided into two different groups: heart failure with preserved or reduced ejection fraction. In recent years, accumulating studies showed that increased mortality and morbidity rates
Jia Li, Peter Moritz Becher, Stefan Blankenberg, Dirk Westermann   +3 more
doaj   +1 more source

Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme [PDF]

, 2016
Aims We investigated the association between worsening renal function (WRF) that occurs during renin–angiotensin–aldosterone system inhibition initation and outcome in heart failure (HF) patients with preserved ejection fraction (HFPEF) and compared ...
Brenner, Clark, Damman, Damman, Damman, Hillege, Lesogor, Lewis, Lindenfeld, Massie, McAlister, McMurray, National Institute for Health and Clinical Excellence, Pfeffer, Rossignol, Rossignol, Rusinaru, Swedberg, Testani, Vardeny, Yancy, Yusuf   +21 more
core   +1 more source

Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial

Cardiovascular Diabetology
Background Clinical trials have established the prognostic benefits of sodium‒glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM) and heart failure (HF) with preserved ejection fraction (HFpEF), although the ...
Artem Ovchinnikov, Alexandra Potekhina, Anastasiia Filatova, Olga Svirida, Kristina Zherebchikova, Fail Ageev, Evgeny Belyavskiy   +6 more
doaj   +1 more source

Rehabilitation outcomes of stroke patients with low left ventricular ejection fraction in the subacute rehabilitation phase

Journal of Rehabilitation Medicine, 2018
Objective: To examine the left ventricular ejection fraction in patients with subacute stroke and compare rehabilitation outcomes between those with decreased left ventricular ejection fraction and those without.
Masahiro Tsujikawa, Yohei Otaka, Rei Hasegawa, Kunitsugu Kondo, Kaori Muraoka, Meigen Liu   +5 more
doaj   +1 more source

Biomarkers in Heart Failure with Preserved Ejection Fraction

Cardiac Failure Review, 2022
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder developing from multiple aetiologies with overlapping pathophysiological mechanisms.
Antoni Bayes-Genis, Germán Cediel, Mar Domingo, Pau Codina, Evelyn Santiago, Josep Lupón   +5 more
doaj   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

Molecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley, Michael W. Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare   +5 more
wiley   +1 more source

Heart failure with preserved ejection fraction: insights from recent clinical researches [PDF]

The Korean Journal of Internal Medicine, 2020
Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for nearly half of the cases of HF and its incidence might be increasing with the aging society.
Mi-Na Kim, Seong-Mi Park
doaj   +1 more source